	CanRisk-GP protocol: A feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice. PLoS One Stutzin Donoso F, Archer S, Walter FM, Morris S, Emery J, Broome J, Carver T, Dennis J, Ficorella L, Lafont A, Stokes AE, Stylianou L, Wilson C, Easton DF, Tischkowitz M, Antoniou AC, Usher-Smith JA. PMID: 41296773 [PubMed - indexed for MEDLINE]
	Challenges & recommendations for identification of human epidermal growth factor receptor -2 (HER2)-low metastatic breast cancer in India: Expert opinion statement. Indian J Med Res Arora N, Bajpai J, Bal A, Batra A, Gupta A, Mishra DK, Mukherjee G, Pai T, Parihar M, Okaly GVP, Prabhudesai S, Shah M, S P S. PMID: 41296586 [PubMed - indexed for MEDLINE]
	Efficacy & safety of sodium-glucose cotransporter-2 inhibitors in polycystic ovary syndrome: A meta-analysis with trial sequential analysis. Indian J Med Res Ahsan M, Mallick AK. PMID: 41296583 [PubMed - indexed for MEDLINE]
	Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer. JAMA Netw Open Taylor M, Westvold SJ, Long JB, Hyslop T, Silber A, Forman R, Yasin F, Kwaramba T, Wang SY, Leapman MS, Cecchini M, Leeds I, Spees L, Wheeler SB, Gross CP, Oeffinger K, Dinan MA. PMID: 41296485 [PubMed - indexed for MEDLINE]
	Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis. J Manag Care Spec Pharm Kiener T, Li KH, Chiang E, Le QA. PMID: 41296320 [PubMed - indexed for MEDLINE]
	Causal relationship between blood metal levels and breast cancer risk: a Mendelian randomization study in East Asian populations. Discov Oncol Zhang J, Xiong F, Hu S, Chen J, Yuan J, Che Y, Sun X. PMID: 41296249 [PubMed - as supplied by publisher]
	Level of DNA damage in peripheral blood mononuclear cells in endometrial cancer patients according to histological type and tumor differentiation. Mol Biol Rep Markovi, , Milo. PMID: 41296163 [PubMed - indexed for MEDLINE]
	Impact of practising an adapted and collective physical activity, such as five-a-side touch rugby, on the physical self-esteem of patients treated or followed up for breast or gynaecological cancer. Support Care Cancer Saxod D, Vergriete K, Migliorelli F, Martinez A, Cornou C, Poussel M, Buffeteau A, Lambaudie E, Weyl A, Motton S. PMID: 41296092 [PubMed - indexed for MEDLINE]
	Double-Blind Randomized Phase 2 Trial Testing Personal Cancer Vaccines in Patients with Advanced Ovarian Cancer. Vaccines (Basel) Abaid LN, Corr BR, Eskander RN, Mason JR, Lopez KL, Godding K, Robles RM, Keirstead HS, Nistor GI, Dillman RO. PMID: 41295472 [PubMed]
	Identification of Chemotherapy-Induced Peripheral Neuropathy-A Self-Administered Scoring System Tested in Breast Cancer Survivors: Protocol of the NEURO-BREAC Trial. J Pers Med Rades D, Streubel MK, Doehring L, Rody A, Ballegaard M. PMID: 41295256 [PubMed]
	Leveraging Synergy: A Review of the Therapeutic Potential of SN-38 and Immune Checkpoint Blockade in Breast and Prostate Cancer Treatment. J Pers Med Adekiya TA, Adesina SK. PMID: 41295214 [PubMed]
	Explainable Radiomics-Based Model for Automatic Image Quality Assessment in Breast Cancer DCE MRI Data. J Imaging Ioannidis GS, Nikiforaki K, Dovrou A, Kilintzis V, Kalliatakis G, Diaz O, Lekadir K, Marias K. PMID: 41295134 [PubMed]
	MicroRNA Signatures in Serous Ovarian Cancer: A Comparison of Prognostic Marker Targets in African Americans and Caucasians. Diseases Muinde JM, Yamauchi CR, Cruz J, McQuarter AA, Miller K, Sharma U, Schiff S, Kremsky I, Mirshahidi S, Carter CS, Khan S. PMID: 41294900 [PubMed]
	Integrin Î±vÎ²3 as a Non-Genomic Estrogen Receptor in Breast Cancer for Signaling Pathways and Crosstalk. Cells Wang K, Li ZL, Huang LY, Yao CJ, Crawford DR, Wang CY, Mo JK, Shih YJ, Lin HY, Whang-Peng J. PMID: 41294885 [PubMed - indexed for MEDLINE]
	The Role of Microbiota in Ovarian Cancer: Implications for Treatment Response and Therapeutic Strategies. Cells Blanco JR, Del Campo R, Avendaño-Ortiz J, Laguna-Olmos M, Carnero A. PMID: 41294866 [PubMed - indexed for MEDLINE]
	CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes. Cells Bucheeri S, Alcibahy Y, Bucheeri Y, Bucheeri S, Alhermi A, Butler AE. PMID: 41294822 [PubMed - indexed for MEDLINE]
	MFF-ClassificationNet: CNN-Transformer Hybrid with Multi-Feature Fusion for Breast Cancer Histopathology Classification. Biosensors (Basel) Wang X, Wang G, Li L, Zou H, Cui J. PMID: 41294730 [PubMed - indexed for MEDLINE]
	Parotid Gland Mass as the First Manifestation of Recurrent Metastatic Breast Carcinoma: Diagnostic Pitfalls and Therapeutic Considerations in Oral-Maxillofacial Care. Curr Oncol Mar-Uribe ER, Noyola-Frías MA, Benítez-Cárdenas OA, Torres-Hernández EM, Mosqueda-Taylor A, Sánchez-Gutiérrez R, Bernal-Silva S, Comas-García A, Aguilar-Zapata FJ, Martínez-Rider R, Vitales-Noyola M. PMID: 41294696 [PubMed - indexed for MEDLINE]
	Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study. Curr Oncol Bayram S, Tatli AM, Cakir MO, Ozdogan M. PMID: 41294665 [PubMed - indexed for MEDLINE]
	Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy. Curr Oncol Ibis K, Durmaz M, Yanik D, Bunul I, Denizli M, Akyuz E, Khishigsuren B, Celik AI, Kartal MGD, Kucucuk NS, Yirgin IK, Emec M. PMID: 41294664 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 247990

Page 1 of 12400



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy